NASDAQ:VNDA - Nasdaq - US9216591084 - Common Stock - Currency: USD
Taking everything into account, VNDA scores 3 out of 10 in our fundamental rating. VNDA was compared to 568 industry peers in the Biotechnology industry. There are concerns on the financial health of VNDA while its profitability can be described as average. VNDA does not seem to be growing, but still is valued expensively.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -2.88% | ||
ROE | -3.51% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 94.31% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.01 | ||
Debt/FCF | N/A | ||
Altman-Z | 1.63 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.39 | ||
Quick Ratio | 4.37 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:VNDA (4/21/2025, 12:59:33 PM)
4.31
-0.02 (-0.46%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 1.26 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 0.47 | ||
P/tB | 0.59 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -2.88% | ||
ROE | -3.51% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 94.31% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.01 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 6.03% | ||
Cap/Sales | 0.25% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 4.39 | ||
Quick Ratio | 4.37 | ||
Altman-Z | 1.63 |